Aura Biosciences Inc

NASDAQ:AURA   4:00:00 PM EDT
12.25
-0.13 (-1.05%)
4:01:53 PM EDT: $12.25 0.00 (0.00%)
Earnings Announcements

Aura Biosciences Reports Q3 2022 Results

Published: 11/10/2022 12:34 GMT
Aura Biosciences Inc (AURA) - Aura Biosciences Reports Third Quarter 2022 Financial Results and Provides Clinical Development and Operational Highlights.
Believes Its Current Cash and Cash Equivalents and Marketable Securities Are Sufficient to Fund Its Operations Into 2024.
Qtrly Loss per Share $0.54.
Q3 Earnings per Share View $-0.51 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.54

More details on our Analysts Page.